NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers
- Status
- COMPLETED
- Phase
- PHASE2
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Evaluate Gemcitabine Plus Cisplatin in the Treatment of TNBC Patients Following Neoadjuvant Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
- Status
- TERMINATED
- Phase
- PHASE1
Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women
- Status
- WITHDRAWN
- Phase
- N/A
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Bisphenol and Phthalate Exposures in Triple Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- N/A
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Sacituzumab Govitecan In TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment
- Status
- TERMINATED
- Phase
- PHASE1
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1